The management of thrombotic lesions in the cardiac catheterization laboratory

Journal of Cardiovascular Translational Research

Volumn 5, Issue 1, 2012, Pages 52-61

  Matar, Fadi ^a   Mroue, Jad ^b  

^a TAMPA GENERAL HOSPITAL   (United States)

^b SAINT JOSEPH UNIVERSITY   (Lebanon)

Author keywords

Acute coronary syndrome; Antiplatelet agents; Antithrombins; Coronary thrombosis; Direct thrombin inhibitors; Embolic protection; Glycoprotein 2b 3a inhibitors; Percutaneous coronary intervention; Thrombectomy

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ADENOSINE; ANTICOAGULANT AGENT; ENOXAPARIN; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; HEPARIN; HIRULOG; NITROPRUSSIDE SODIUM; TIROFIBAN; TROPONIN T; VERAPAMIL;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; CLINICAL PRACTICE; COMPARATIVE EFFECTIVENESS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; DEVICE THERAPY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE MARKER; DRUG BINDING; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; EMBOLIC PROTECTION DEVICE; HEART CATHETERIZATION; HEART DEATH; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; INTRACARDIAC THROMBOSIS; ISCHEMIA; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; REPERFUSION INJURY; REVIEW; RHEOLYTIC THROMBECTOMY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; THROMBECTOMY; THROMBOCYTE AGGREGATION INHIBITION; THROMBUS; TREATMENT INDICATION;

ACUTE CORONARY SYNDROME; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; EMBOLIC PROTECTION DEVICES; EVIDENCE-BASED MEDICINE; HEART CATHETERIZATION; HUMANS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; PREVALENCE; SUCTION; THROMBECTOMY; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

ANGINA;

EID: 84859791391     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-011-9327-6     Document Type: Review

References (86)

1. (1999). Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet, 354(9180), 708-715.
2. Cannon, C. P., Weintraub, W. S., Demopoulos, L. A., Vicari, R., Frey, M. J., Lakkis, N., et al. (2001). Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. The New England Journal of Medicine, 344(25), 1879-1887. (Pubitemid 32564900)
3. Wallentin, L., Lagerqvist, B., Husted, S., Kontny, F., Stahle, E., & Swahn, E. (2000). Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during InStability in Coronary artery disease. Lancet, 356(9223), 9-16. (Pubitemid 30416988)
4. Fox, K. A., Poole-Wilson, P. A., Henderson, R. A., Clayton, T. C., Chamberlain, D. A., Shaw, T. R., et al. (2002). Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet, 360(9335), 743-751. (Pubitemid 35247703)
5. Mehta, S. R., Granger, C. B., Boden, W. E., Steg, P. G., Bassand, J. P., Faxon, D. P., et al. (2009). Early versus delayed invasive intervention in acute coronary syndromes. The New England Journal of Medicine, 360(21), 2165-2175.
6. Neumann, F. J., Kastrati, A., Pogatsa-Murray, G., Mehilli, J., Bollwein, H., Bestehorn, H. P., et al. (2003). Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. Journal of the American Medical Association, 290(12), 1593-1599. (Pubitemid 37441261)
7. DeWood,M.A., Spores, J., Notske, R.,Mouser, L. T., Burroughs, R., Golden, M. S., et al. (1980). Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. The New England Journal of Medicine, 303(16), 897-902.
8. (1993). Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial. Circulation, 87(1), 38-52.
9. Gibson, C. M., de Lemos, J. A., Murphy, S. A., Marble, S. J., McCabe, C. H., Cannon, C. P., et al. (2001). Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation, 103 (21), 2550-2554. (Pubitemid 32521963)
10. Gotoh, K., Minamino, T., Katoh, O., Hamano, Y., Fukui, S., Hori, M., et al. (1988). The role of intracoronary thrombus in unstable angina: angiographic assessment and thrombolytic therapy during ongoing anginal attacks. Circulation, 77(3), 526-534. (Pubitemid 18073344)
11. Freeman, M. R., Williams, A. E., Chisholm, R. J., & Armstrong, P. W. (1989). Intracoronary thrombus and complex morphology in unstable angina. Relation to timing of angiography and in-hospital cardiac events. Circulation, 80(1), 17-23.
12. Napodano, M., Ramondo, A., Tarantini, G., Peluso, D., Compagno, S., Fraccaro, C., et al. (2009). Predictors and time-related impact of distal embolization during primary angioplasty. European Heart Journal, 30(3), 305-313.
13. Zhao, X. Q., Theroux, P., Snapinn, S. M., & Sax, F. L. (1999). Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISMPLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and symptoms). PRISM-PLUS Investigators. Circulation, 100(15), 1609-1615.
14. Henriques, J. P., Zijlstra, F., Ottervanger, J. P., de Boer, M. J., van 't Hof, A. W., Hoorntje, J. C., et al. (2002). Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. European Heart Journal, 23(14), 1112-1117. (Pubitemid 35230716)
15. Falk, E., Shah, P. K., & Fuster, V. (1995). Coronary plaque disruption. Circulation, 92(3), 657-671.
16. Davies, M. J. (1996). Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White lecture 1995. Circulation, 94(8), 2013-2020.
17. Davies, M. J. (1997). The composition of coronary-artery plaques. The New England Journal of Medicine, 336(18), 1312-1314.
18. Davies, M. J., & Thomas, A. (1984). Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. The New England Journal of Medicine, 310(18), 1137-1140. (Pubitemid 14135387)
19. Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992). The pathogenesis of coronary artery disease and the acute coronary syndromes (2). The New England Journal of Medicine, 326(5), 310-318.
20. Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992). The pathogenesis of coronary artery disease and the acute coronary syndromes (1). The New England Journal of Medicine, 326(4), 242-250.
21. Farb, A., Burke, A. P., Tang, A. L., Liang, T. Y., Mannan, P., Smialek, J., et al. (1996). Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation, 93(7), 1354-1363.
22. Hackett, D., Davies, G., Chierchia, S., & Maseri, A. (1987). Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy. The New England Journal of Medicine, 317(17), 1055-1059. (Pubitemid 17146897)
23. Saraf, S., Christopoulos, C., Salha, I. B., Stott, D. J., & Gorog, D. A. (2010). Impaired endogenous thrombolysis in acute coronary syndrome patients predicts cardiovascular death and nonfatal myocardial infarction. J Am Coll Cardiol, 55(19), 2107-2115.
24. Mizuno, K., Satomura, K., Miyamoto, A., Arakawa, K., Shibuya, T., Arai, T., et al. (1992). Angioscopic evaluation of coronaryartery thrombi in acute coronary syndromes. The New England Journal of Medicine, 326(5), 287-291.
25. Anderson, H. V., Cannon, C. P., Stone, P. H., Williams, D. O., McCabe, C. H., Knatterud, G. L., et al. (1995). One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. Journal of the American College of Cardiology, 26(7), 1643-1650.
26. Davies, M. J., Thomas, A. C., Knapman, P. A., & Hangartner, J. R. (1986). Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation, 73(3), 418-427. (Pubitemid 16133019)
27. Sherman, C. T., Litvack, F., Grundfest, W., Lee, M., Hickey, A., Chaux, A., et al. (1986). Coronary angioscopy in patients with unstable angina pectoris. The New England Journal of Medicine, 315(15), 913-919. (Pubitemid 16023677)
28. Sianos, G., Papafaklis, M. I., Daemen, J., Vaina, S., van Mieghem, C. A., van Domburg, R. T., et al. (2007). Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. Journal of the American College of Cardiology, 50(7), 573-583. (Pubitemid 47198999)
29. Holmes, D. R., Jr., Hartzler, G. O., Smith, H. C., & Fuster, V. (1981). Coronary artery thrombosis in patients with unstable angina. British Heart Journal, 45(4), 411-416. (Pubitemid 11120502)
30. Vetrovec, G. W., Cowley, M. J., Overton, H., & Richardson, D. W. (1981). Intracoronary thrombus in syndromes of unstable myocardial ischemia. American Heart Journal, 102(6 Pt 2), 1202-1208. (Pubitemid 12198307)
31. Zack, P. M., Ischinger, T., Aker, U. T., Dincer, B., & Kennedy, H. L. (1984). The occurrence of angiographically detected intracoronary thrombus in patients with unstable angina pectoris. American Heart Journal, 108(6), 1408-1412. (Pubitemid 15075889)
32. Lindahl, B., Diderholm, E., Lagerqvist, B., Venge, P., & Wallentin, L. (2001). Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. Journal of the American College of Cardiology, 38(4), 979-986. (Pubitemid 32912698)
33. White, C. J., Ramee, S. R., Collins, T. J., Escobar, A. E., Karsan, A., Shaw, D., et al. (1996). Coronary thrombi increase PTCA risk. Angioscopy as a clinical tool. Circulation, 93(2), 253-258.
34. Singh, M., Berger, P. B., Ting, H. H., Rihal, C. S., Wilson, S. H., Lennon, R. J., et al. (2001). Influence of coronary thrombus on outcome of percutaneous coronary angioplasty in the current era (the Mayo Clinic experience). The American Journal of Cardiology, 88(10), 1091-1096. (Pubitemid 33043837)
35. de Feyter, P. J., de Jaegere, P. P., Murphy, E. S., & Serruys, P. W. (1992). Abrupt coronary artery occlusion during percutaneous transluminal coronary angioplasty. American Heart Journal, 123 (6), 1633-1642.
36. de Feyter, P. J., van den Brand, M., Laarman, G. J., van Domburg, R., Serruys, P. W., & Suryapranata, H. (1991). Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Frequency, prediction, clinical course, management, and follow-up. Circulation, 83(3), 927-936.
37. Napodano, M., Pasquetto, G., Sacca, S., Cernetti, C., Scarabeo, V., Pascotto, P., et al. (2003). Intracoronary thrombectomy improves myocardial reperfusion in patients undergoing direct angioplasty for acute myocardial infarction. Journal of the American College of Cardiology, 42(8), 1395-1402. (Pubitemid 37267279)
38. Antman, E. M. (2001). The search for replacements for unfractionated heparin. Circulation, 103(18), 2310-2314.
39. Cohen, M., Demers, C., Gurfinkel, E. P., Turpie, A. G., Fromell, G. J., Goodman, S., et al. (1997). A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. The New England Journal of Medicine, 337(7), 447-452. (Pubitemid 27333045)
40. Antman, E. M., McCabe, C. H., Gurfinkel, E. P., Turpie, A. G., Bernink, P. J., Salein, D., et al. (1999). Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation, 100(15), 1593-1601.
41. Dumaine, R., Borentain, M., Bertel, O., Bode, C., Gallo, R., White, H. D., et al. (2007). Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials. Archives of Internal Medicine, 167(22), 2423-2430. (Pubitemid 350258448)
42. Stone, G. W., McLaurin, B. T., Cox, D. A., Bertrand, M. E., Lincoff, A. M., Moses, J. W., et al. (2006). Bivalirudin for patients with acute coronary syndromes. The New England Journal of Medicine, 355(21), 2203-2216. (Pubitemid 44791162)
43. Stone, G. W., Witzenbichler, B., Guagliumi, G., Peruga, J. Z., Brodie, B. R., Dudek, D., et al. (2008). Bivalirudin during primary PCI in acute myocardial infarction. The New England Journal of Medicine, 358(21), 2218-2230. (Pubitemid 351724451)
44. (1997). Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis. Circulation, 96 (5), 1445-1453.
45. (1997). Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study. Lancet, 349(9063), 1429-1435.
46. (1997). Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II. Lancet, 349(9063), 1422-1428.
47. (1994). Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation. N Engl J Med, 330(14), 956-961.
48. Collet, J. P., Montalescot, G., Lesty, C., Mishal, Z., Soria, J., Choussat, R., et al. (2001). Effects of Abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary intervention. Circulation, 103(19), 2328-2331. (Pubitemid 32448794)
49. Collet, J. P., Montalescot, G., Lesty, C., Soria, J., Mishal, Z., Thomas, D., et al. (2001). Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis. Arteriosclerosis, Thrombosis, and Vascular Biology, 21(1), 142-148. (Pubitemid 32061939)
50. Collet, J. P., Montalescot, G., Lesty, C., & Weisel, J. W. (2002). A structural and dynamic investigation of the facilitating effect of glycoprotein IIb/IIIa inhibitors in dissolving platelet-rich clots. Circulation Research, 90(4), 428-434. (Pubitemid 34633912)
51. Marciniak, S. J., Jr., Mascelli, M. A., Furman, M. I., Michelson, A. D., Jakubowski, J. A., Jordan, R. E., et al. (2002). An additional mechanism of action of abciximab: dispersal of newly formed platelet aggregates. Thrombosis and Haemostasis, 87(6), 1020-1025. (Pubitemid 34624885)
52. Moser, M., Bertram, U., Peter, K., Bode, C., & Ruef, J. (2003). Abciximab, eptifibatide, and tirofiban exhibit dose-dependent potencies to dissolve platelet aggregates. Journal of Cardiovascular Pharmacology, 41(4), 586-592. (Pubitemid 36373796)
53. van den Brand, M., Laarman, G. J., Steg, P. G., De Scheerder, I., Heyndrickx, G., Beatt, K., et al. (1999). Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients. Angiographic results from the CAPTURE trial. European Heart Journal, 20(21), 1572-1578. (Pubitemid 29525156)
54. De Lemos, J. A., Antman, E. M., Gibson, C. M., McCabe, C. H., Giugliano, R. P., Murphy, S. A., et al. (2000). Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial. Circulation, 101(3), 239-243. (Pubitemid 30054149)
55. Neumann, F. J., Blasini, R., Schmitt, C., Alt, E., Dirschinger, J., Gawaz, M., et al. (1998). Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation, 98(24), 2695-2701. (Pubitemid 28564004)
56. Gibson, C. M., Murphy, S. A., Rizzo, M. J., Ryan, K. A., Marble, S. J., McCabe, C. H., et al. (1999). Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis in Myocardial Infarction (TIMI) Study Group. Circulation, 99(15), 1945-1950. (Pubitemid 29183889)
57. Thiele, H., Schindler, K., Friedenberger, J., Eitel, I., Furnau, G., Grebe, E., et al. (2008). Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial. Circulation, 118(1), 49-57.
58. Pomerantz, R. M., Kuntz, R. E., Diver, D. J., Safian, R. D., & Baim, D. S. (1991). Intracoronary verapamil for the treatment of distal microvascular coronary artery spasm following PTCA. Catheterization and Cardiovascular Diagnosis, 24(4), 283-285.
59. Kaplan, B. M., Benzuly, K. H., Kinn, J. W., Bowers, T. R., Tilli, F. V., Grines, C. L., et al. (1996). Treatment of no-reflow in degenerated saphenous vein graft interventions: comparison of intracoronary verapamil and nitroglycerin. Catheterization and Cardiovascular Diagnosis, 39(2), 113-118.
60. Kaminski, P. M., & Proctor, K. G. (1989). Attenuation of no-reflow phenomenon, neutrophil activation, and reperfusion injury in intestinal microcirculation by topical adenosine. Circulation Research, 65(2), 426-435. (Pubitemid 19194629)
61. Micari, A., Belcik, T. A., Balcells, E. A., Powers, E., Wei, K., Kaul, S., et al. (2005). Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary coronary stenting. The American Journal of Cardiology, 96(10), 1410-1415. (Pubitemid 41566624)
62. Movahed, M. R., & Baweja, G. (2008). Distal administration of very high doses of intracoronary adenosine for the treatment of resistant no-reflow. Experimental and Clinical Cardiology, 13(3), 141-143.
63. Parikh, K. H., Chag, M. C., Shah, K. J., Shah, U. G., Baxi, H. A., Chandarana, A. H., et al. (2007). Intracoronary boluses of adenosine and sodium nitroprusside in combination reverses slow/no-reflow during angioplasty: a clinical scenario of ischemic preconditioning. Canadian Journal of Physiology and Pharmacology, 85(3-4), 476-482. (Pubitemid 47262253)
64. Hillegass, W. B., Dean, N. A., Liao, L., Rhinehart, R. G., & Myers, P. R. (2001). Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience. Journal of the American College of Cardiology, 37(5), 1335-1343.
65. Grines, C., Patel, A., Zijlstra, F., Weaver, W. D., Granger, C., & Simes, R. J. (2003). Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials. American Heart Journal, 145(1), 47-57. (Pubitemid 36034497)
66. Grines, C. L., Browne, K. F., Marco, J., Rothbaum, D., Stone, G. W., O'Keefe, J., et al. (1993). A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. The New England Journal of Medicine, 328(10), 673-679. (Pubitemid 23073368)
67. Grines, C. L., Cox, D. A., Stone, G. W., Garcia, E., Mattos, L. A., Giambartolomei, A., et al. (1999). Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. The New England Journal of Medicine, 341(26), 1949-1956. (Pubitemid 30010402)
68. Burzotta, F., De Vita, M., Gu, Y. L., Isshiki, T., Lefevre, T., Kaltoft, A., et al. (2009). Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patientdata pooled analysis of 11 trials. European Heart Journal, 30(18), 2193-2203.
69. Tamhane, U. U., Chetcuti, S., Hameed, I., Grossman, P. M., Moscucci, M., & Gurm, H. S. (2010). Safety and efficacy of thrombectomy in patients undergoing primary percutaneous coronary intervention for acute ST elevation MI: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord, 10, 10.
70. Burzotta, F., Trani, C., Romagnoli, E., Mazzari, M. A., Rebuzzi, A. G., De Vita, M., et al. (2005). Manual thrombus-aspiration improves myocardial reperfusion: the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial. Journal of the American College of Cardiology, 46(2), 371-376. (Pubitemid 40966871)
71. De Luca, L., Sardella, G., Davidson, C. J., De Persio, G., Beraldi, M., Tommasone, T., et al. (2006). Impact of intracoronary aspiration thrombectomy during primary angioplasty on left ventricular remodelling in patients with anterior ST elevation myocardial infarction. Heart, 92(7), 951-957. (Pubitemid 43974060)
72. Ikari, Y., Sakurada, M., Kozuma, K., Kawano, S., Katsuki, T., Kimura, K., et al. (2008). Upfront thrombus aspiration in primary coronary intervention for patients with ST-segment elevation acute myocardial infarction: report of the VAMPIRE (VAcuuM asPIration thrombus REmoval) trial. JACC. Cardiovascular Interventions, 1(4), 424-431.
73. Kaltoft, A., Bottcher, M., Nielsen, S. S., Hansen, H. H., Terkelsen, C., Maeng, M., et al. (2006). Routine thrombectomy in percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction: a randomized, controlled trial. Circulation, 114(1), 40-47. (Pubitemid 44305273)
74. Lefevre, T., Garcia, E., Reimers, B., Lang, I., di Mario, C., Colombo, A., et al. (2005). X-sizer for thrombectomy in acute myocardial infarction improves ST-segment resolution: results of the X-sizer in AMI for negligible embolization and optimal ST resolution (X AMINE ST) trial. Journal of the American College of Cardiology, 46(2), 246-252. (Pubitemid 40966851)
75. Sardella, G., Mancone, M., Bucciarelli-Ducci, C., Agati, L., Scardala, R., Carbone, I., et al. (2009). Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial. Journal of the American College of Cardiology, 53(4), 309-315.
76. Silva-Orrego, P., Colombo, P., Bigi, R., Gregori, D., Delgado, A., Salvade, P., et al. (2006). Thrombus aspiration before primary angioplasty improves myocardial reperfusion in acute myocardial infarction: the DEAR-MI (Dethrombosis to Enhance Acute Reperfusion in Myocardial Infarction) study. Journal of the American College of Cardiology, 48(8), 1552-1559. (Pubitemid 44528191)
77. Stone, G. W., Cox, D. A., Babb, J., Nukta, D., Bilodeau, L., Cannon, L., et al. (2003). Prospective, randomized evaluation of thrombectomy prior to percutaneous intervention in diseased saphenous vein grafts and thrombus-containing coronary arteries. Journal of the American College of Cardiology, 42(11), 2007-2013. (Pubitemid 37485580)
78. Svilaas, T., Vlaar, P. J., van der Horst, I. C., Diercks, G. F., de Smet, B. J., van den Heuvel, A. F., et al. (2008). Thrombus aspiration during primary percutaneous coronary intervention. The New England Journal of Medicine, 358(6), 557-567. (Pubitemid 351214283)
79. Ali, A., Cox, D., Dib, N., Brodie, B., Berman, D., Gupta, N., et al. (2006). Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study. Journal of the American College of Cardiology, 48(2), 244-252.
80. Migliorini, A., Stabile, A., Rodriguez, A. E., Gandolfo, C., Rodriguez Granillo, A. M., Valenti, R., et al. (2010). Comparison of AngioJet rheolytic thrombectomy before direct infarct artery stenting with direct stenting alone in patients with acute myocardial infarction. The JETSTENT trial. J Am Coll Cardiol, 56(16), 1298-1306.
81. Matar, F., Gloer, K., Barrett, C., Sires, O., Thakore, S., Warner, J., et al. (2006). Synergism of rheolytic thrombectomy and embolic distal protection using the percusurge guard wire for fresh thrombus removal: an in vitro study. Acute Cardiac Care, 8(1), 31-34.
82. Baim, D. S., Wahr, D., George, B., Leon, M. B., Greenberg, J., Cutlip, D. E., et al. (2002). Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation, 105(11), 1285-1290. (Pubitemid 34260417)
83. Stone, G. W., Webb, J., Cox, D. A., Brodie, B. R., Qureshi, M., Kalynych, A., et al. (2005). Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. Journal of the American Medical Association, 293(9), 1063-1072. (Pubitemid 40300280)
84. Gick, M., Jander, N., Bestehorn, H. P., Kienzle, R. P., Ferenc, M., Werner, K., et al. (2005). Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation. Circulation, 112(10), 1462-1469. (Pubitemid 41294506)
85. Kelbaek, H., Terkelsen, C. J., Helqvist, S., Lassen, J. F., Clemmensen, P., Klovgaard, L., et al. (2008). Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial. Journal of the American College of Cardiology, 51 (9), 899-905. (Pubitemid 351282452)
86. Matar, F. A., Smith, K., Rossi, P., Vandormael, M., Sullebarger, J. T., Taylor, M., et al. (2009). Limitations of embolic protection in saphenous vein graft intervention: insights from 202 consecutive patients. Journal of Interventional Cardiology, 22(3), 240-246.